Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Better support for children with additional health and developmental needs in school settings: Perspectives of education experts.

Garvey W, O'Connor M, Quach J, Goldfeld S.

Child Care Health Dev. 2020 Mar 19. doi: 10.1111/cch.12766. [Epub ahead of print]

PMID:
32191353
2.

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial.

Garvey WT, Birkenfeld AL, Dicker D, Mingrone G, Pedersen SD, Satylganova A, Skovgaard D, Sugimoto D, Jensen C, Mosenzon O.

Diabetes Care. 2020 Mar 5. pii: dc191745. doi: 10.2337/dc19-1745. [Epub ahead of print]

PMID:
32139381
3.

Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity.

Garvey WT, Mechanick JI.

Obesity (Silver Spring). 2020 Mar;28(3):484-492. doi: 10.1002/oby.22727. Review.

PMID:
32090513
4.

Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review.

Mechanick JI, Farkouh ME, Newman JD, Garvey WT.

J Am Coll Cardiol. 2020 Feb 11;75(5):539-555. doi: 10.1016/j.jacc.2019.11.046. Review.

PMID:
32029137
5.

Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review.

Mechanick JI, Farkouh ME, Newman JD, Garvey WT.

J Am Coll Cardiol. 2020 Feb 11;75(5):525-538. doi: 10.1016/j.jacc.2019.11.044. Review.

PMID:
32029136
6.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.

Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, Barzilay JI, Blonde L, Bush MA, DeFronzo RA, Garber JR, Garvey WT, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Perreault L, Rosenblit PD, Samson S, Umpierrez GE.

Endocr Pract. 2020 Jan;26(1):107-139. doi: 10.4158/CS-2019-0472.

PMID:
32022600
7.

Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes.

Schulte EM, Tuerk PW, Wadden TA, Garvey WT, Weiss D, Hermayer KL, Aronne LJ, Becker LE, Fujioka K, Miller-Kovach K, Kushner RF, Malcolm RJ, Raum WJ, Rost SL, Rubino DM, Sora ND, Veliko JL, O'Neil PM.

Int J Obes (Lond). 2020 Jan 16. doi: 10.1038/s41366-020-0530-x. [Epub ahead of print]

PMID:
31949295
8.

Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists.

Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD.

Surg Obes Relat Dis. 2020 Feb;16(2):175-247. doi: 10.1016/j.soard.2019.10.025. Epub 2019 Oct 31.

PMID:
31917200
9.

Race affects the association of obesity measures with insulin sensitivity.

Tay J, Goss AM, Garvey WT, Lockhart ME, Bush NC, Quon MJ, Fisher G, Gower BA.

Am J Clin Nutr. 2020 Mar 1;111(3):515-525. doi: 10.1093/ajcn/nqz309.

PMID:
31879755
10.

CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY.

Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD.

Endocr Pract. 2019 Dec;25(12):1346-1359. doi: 10.4158/GL-2019-0406. Epub 2019 Nov 4.

PMID:
31682518
11.

Exercise plasma metabolomics and xenometabolomics in obese, sedentary, insulin-resistant women: impact of a fitness and weight loss intervention.

Grapov D, Fiehn O, Campbell C, Chandler CJ, Burnett DJ, Souza EC, Casazza GA, Keim NL, Newman JW, Hunter GR, Fernandez JR, Garvey WT, Hoppel CL, Harper ME, Adams SH.

Am J Physiol Endocrinol Metab. 2019 Dec 1;317(6):E999-E1014. doi: 10.1152/ajpendo.00091.2019. Epub 2019 Sep 17.

PMID:
31526287
12.

Core Principles, Treatment Standards, and Provider Competencies for the Care of Patients with Obesity.

Garvey WT.

Obesity (Silver Spring). 2019 Jul;27(7):1045-1047. doi: 10.1002/oby.22538. No abstract available.

PMID:
31231959
13.

Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.

Basu A, Bebu I, Jenkins AJ, Stoner JA, Zhang Y, Klein RL, Lopes-Virella MF, Garvey WT, Budoff MJ, Alaupovic P, Lyons TJ; Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions Complications Research Group.

J Lipid Res. 2019 Aug;60(8):1432-1439. doi: 10.1194/jlr.P090647. Epub 2019 Jun 15.

14.

COMMENTARY FROM THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS ON THE U.S. PREVENTIVE SERVICES TASK FORCE RECOMMANDATIONS REGARDING WEIGHT LOSS INTERVENTIONS.

Garvey WT, Jastreboff AM.

Endocr Pract. 2019 Apr;25(4):394-395. doi: 10.4158/EP-2018-0597. Epub 2019 Apr 23. No abstract available.

PMID:
31013160
15.

Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report.

Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S, Saslow L, Uelmen S, Urbanski PB, Yancy WS Jr.

Diabetes Care. 2019 May;42(5):731-754. doi: 10.2337/dci19-0014. Epub 2019 Apr 18. Review. No abstract available.

PMID:
31000505
16.

Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.

Yassin A, Haider A, Haider KS, Caliber M, Doros G, Saad F, Garvey WT.

Diabetes Care. 2019 Jun;42(6):1104-1111. doi: 10.2337/dc18-2388. Epub 2019 Mar 12.

PMID:
30862651
17.

DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT.

Mechanick JI, Garber AJ, Grunberger G, Handelsman Y, Garvey WT.

Endocr Pract. 2018 Nov;24(11):995-1011. doi: 10.4158/PS-2018-0139.

PMID:
30763128
18.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2019 Jan;25(1):69-100. doi: 10.4158/CS-2018-0535. Erratum in: Endocr Pract. 2019 Feb;25(2):204.

PMID:
30742570
19.

Non-pharmacological approaches to infantile colic: white noise versus swinging.

Garvey W, Sung V.

Evid Based Nurs. 2018 Oct;21(4):112. doi: 10.1136/eb-2018-102875. Epub 2018 Sep 15. No abstract available.

PMID:
30219758
20.

The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.

Chou CF, Hsieh YH, Grubbs CJ, Atigadda VR, Mobley JA, Dummer R, Muccio DD, Eto I, Elmets CA, Garvey WT, Chang PL.

J Dermatol Sci. 2018 Jun;90(3):343-356. doi: 10.1016/j.jdermsci.2018.03.006. Epub 2018 Mar 15.

21.

Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.

Basu A, Jenkins AJ, Stoner JA, Zhang Y, Klein RL, Lopes-Virella MF, Garvey WT, Schade DS, Wood J, Alaupovic P, Lyons TJ; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

J Lipid Res. 2018 May;59(5):872-883. doi: 10.1194/jlr.P080143. Epub 2018 Mar 25.

22.

Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes.

Garvey WT, Van Gaal L, Leiter LA, Vijapurkar U, List J, Cuddihy R, Ren J, Davies MJ.

Metabolism. 2018 Aug;85:32-37. doi: 10.1016/j.metabol.2018.02.002. Epub 2018 Feb 13.

23.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17.

PMID:
29368965
24.

Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings After 12-Week Treatment: A Randomized Substudy.

Rebello CJ, Nikonova EV, Zhou S, Aronne LJ, Fujioka K, Garvey WT, Smith SR, Coulter AA, Greenway FL.

Obesity (Silver Spring). 2018 Feb;26(2):332-339. doi: 10.1002/oby.22094.

25.

Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans.

Ma E, Fu Y, Garvey WT.

Metab Syndr Relat Disord. 2018 Mar;16(2):82-89. doi: 10.1089/met.2017.0101. Epub 2018 Jan 23.

26.

F2-Isoprostanes Reflect Oxidative Stress Correlated With Lean Mass and Bone Density but Not Insulin Resistance.

Ma E, Ingram KH, Milne GL, Garvey WT.

J Endocr Soc. 2017 Apr 7;1(5):436-448. doi: 10.1210/js.2017-00006. eCollection 2017 May 1. Erratum in: J Endocr Soc. 2018 Feb 07;2(3):240.

27.

Leptin, An Adipokine With Central Importance in the Global Obesity Problem.

Mechanick JI, Zhao S, Garvey WT.

Glob Heart. 2018 Jun;13(2):113-127. doi: 10.1016/j.gheart.2017.10.003. Epub 2017 Dec 13. Review.

PMID:
29248361
28.

APPLICATION OF THE AACE/ACE ADVANCED FRAMEWORK FOR THE DIAGNOSIS OF OBESITY AND CARDIOMETABOLIC DISEASE STAGING IN A GENERAL POPULATION FROM 3 REGIONS OF VENEZUELA: THE VEMSOLS STUDY RESULTS.

Nieto-Martínez R, González-Rivas JP, Ugel E, Brajkovich I, Risquez A, Garvey WT, Mechanick JI.

Endocr Pract. 2018 Jan;24(1):6-13. doi: 10.4158/EP161644.OR. Epub 2017 Nov 6.

PMID:
29106817
29.

Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.

Wheeler E, Leong A, Liu CT, Hivert MF, Strawbridge RJ, Podmore C, Li M, Yao J, Sim X, Hong J, Chu AY, Zhang W, Wang X, Chen P, Maruthur NM, Porneala BC, Sharp SJ, Jia Y, Kabagambe EK, Chang LC, Chen WM, Elks CE, Evans DS, Fan Q, Giulianini F, Go MJ, Hottenga JJ, Hu Y, Jackson AU, Kanoni S, Kim YJ, Kleber ME, Ladenvall C, Lecoeur C, Lim SH, Lu Y, Mahajan A, Marzi C, Nalls MA, Navarro P, Nolte IM, Rose LM, Rybin DV, Sanna S, Shi Y, Stram DO, Takeuchi F, Tan SP, van der Most PJ, Van Vliet-Ostaptchouk JV, Wong A, Yengo L, Zhao W, Goel A, Martinez Larrad MT, Radke D, Salo P, Tanaka T, van Iperen EPA, Abecasis G, Afaq S, Alizadeh BZ, Bertoni AG, Bonnefond A, Böttcher Y, Bottinger EP, Campbell H, Carlson OD, Chen CH, Cho YS, Garvey WT, Gieger C, Goodarzi MO, Grallert H, Hamsten A, Hartman CA, Herder C, Hsiung CA, Huang J, Igase M, Isono M, Katsuya T, Khor CC, Kiess W, Kohara K, Kovacs P, Lee J, Lee WJ, Lehne B, Li H, Liu J, Lobbens S, Luan J, Lyssenko V, Meitinger T, Miki T, Miljkovic I, Moon S, Mulas A, Müller G, Müller-Nurasyid M, Nagaraja R, Nauck M, Pankow JS, Polasek O, Prokopenko I, Ramos PS, Rasmussen-Torvik L, Rathmann W, Rich SS, Robertson NR, Roden M, Roussel R, Rudan I, Scott RA, Scott WR, Sennblad B, Siscovick DS, Strauch K, Sun L, Swertz M, Tajuddin SM, Taylor KD, Teo YY, Tham YC, Tönjes A, Wareham NJ, Willemsen G, Wilsgaard T, Hingorani AD; EPIC-CVD Consortium; EPIC-InterAct Consortium; Lifelines Cohort Study, Egan J, Ferrucci L, Hovingh GK, Jula A, Kivimaki M, Kumari M, Njølstad I, Palmer CNA, Serrano Ríos M, Stumvoll M, Watkins H, Aung T, Blüher M, Boehnke M, Boomsma DI, Bornstein SR, Chambers JC, Chasman DI, Chen YI, Chen YT, Cheng CY, Cucca F, de Geus EJC, Deloukas P, Evans MK, Fornage M, Friedlander Y, Froguel P, Groop L, Gross MD, Harris TB, Hayward C, Heng CK, Ingelsson E, Kato N, Kim BJ, Koh WP, Kooner JS, Körner A, Kuh D, Kuusisto J, Laakso M, Lin X, Liu Y, Loos RJF, Magnusson PKE, März W, McCarthy MI, Oldehinkel AJ, Ong KK, Pedersen NL, Pereira MA, Peters A, Ridker PM, Sabanayagam C, Sale M, Saleheen D, Saltevo J, Schwarz PE, Sheu WHH, Snieder H, Spector TD, Tabara Y, Tuomilehto J, van Dam RM, Wilson JG, Wilson JF, Wolffenbuttel BHR, Wong TY, Wu JY, Yuan JM, Zonderman AB, Soranzo N, Guo X, Roberts DJ, Florez JC, Sladek R, Dupuis J, Morris AP, Tai ES, Selvin E, Rotter JI, Langenberg C, Barroso I, Meigs JB.

PLoS Med. 2017 Sep 12;14(9):e1002383. doi: 10.1371/journal.pmed.1002383. eCollection 2017 Sep.

30.

Obesity: Obesity and cardiometabolic disease - more than meets the eye.

Aslibekyan S, Garvey WT.

Nat Rev Endocrinol. 2017 Oct;13(10):566-568. doi: 10.1038/nrendo.2017.112. Epub 2017 Sep 1. No abstract available.

PMID:
28862269
31.

Childhood Maltreatment Is an Independent Risk Factor for Prediabetic Disturbances in Glucose Regulation.

Li L, Garvey WT, Gower BA.

Front Endocrinol (Lausanne). 2017 Jun 30;8:151. doi: 10.3389/fendo.2017.00151. eCollection 2017.

32.

Letter to the Editor.

Mechanick JI, Hurley DL, Garvey WT.

Endocr Pract. 2017 Jul;23(7):888-889. doi: 10.4158/1934-2403-23.7.888. No abstract available.

PMID:
28703649
33.

Letter to the Editor.

Mechanick JI, Hurley DL, Garvey WT.

Endocr Pract. 2017 Jun;23(6):749-750. doi: 10.4158/1934-2403-23.6.749. No abstract available.

PMID:
28614037
35.

Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study.

Smith SR, Garvey WT, Greenway FL, Zhou S, Fain R, Pilson R, Fujioka K, Aronne LJ.

Obesity (Silver Spring). 2017 May;25(5):857-865. doi: 10.1002/oby.21811.

36.

Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial.

Holland-Carter L, Tuerk PW, Wadden TA, Fujioka KN, Becker LE, Miller-Kovach K, Hollander PL, Garvey WT, Weiss D, Rubino DM, Kushner RF, Malcolm RJ, Raum WJ, Hermayer KL, Veliko JL, Rost SL, Sora ND, Salyer JL, O'Neil PM.

J Diabetes Complications. 2017 May;31(5):891-897. doi: 10.1016/j.jdiacomp.2017.01.022. Epub 2017 Feb 16.

37.

Reply: Role of Adiponectin: Important or Null?

Mechanick JI, Zhao S, Garvey WT.

J Am Coll Cardiol. 2017 Mar 21;69(11):1518-1519. doi: 10.1016/j.jacc.2016.12.034. No abstract available.

38.

Pharmacotherapy for Weight Management in the VHA.

Semla TP, Ruser C, Good CB, Yanovski SZ, Ames D, Copeland LA, Billington C, Ferguson UI, Aronne LJ, Wadden TA, Garvey WT, Apovian CM, Atkins D.

J Gen Intern Med. 2017 Apr;32(Suppl 1):70-73. doi: 10.1007/s11606-016-3949-y.

40.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2017 Feb;23(2):207-238. doi: 10.4158/EP161682.CS. Epub 2017 Jan 17.

PMID:
28095040
41.

Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.

Lee JH, Kang M, Wang H, Naik G, Mobley JA, Sonpavde G, Garvey WT, Darley-Usmar VM, Ponnazhagan S.

FASEB J. 2017 Apr;31(4):1608-1619. doi: 10.1096/fj.201601178R. Epub 2017 Jan 9.

42.

ADIPOSITY-BASED CHRONIC DISEASE AS A NEW DIAGNOSTIC TERM: THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT.

Mechanick JI, Hurley DL, Garvey WT.

Endocr Pract. 2017 Mar;23(3):372-378. doi: 10.4158/EP161688.PS. Epub 2016 Dec 14.

PMID:
27967229
43.
44.

The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice.

Mechanick JI, Zhao S, Garvey WT.

J Am Coll Cardiol. 2016 Oct 18;68(16):1785-1803. doi: 10.1016/j.jacc.2016.06.072. Review.

45.

Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.

Zhang J, Light AR, Hoppel CL, Campbell C, Chandler CJ, Burnett DJ, Souza EC, Casazza GA, Hughen RW, Keim NL, Newman JW, Hunter GR, Fernandez JR, Garvey WT, Harper ME, Fiehn O, Adams SH.

Exp Physiol. 2017 Jan 1;102(1):48-69. doi: 10.1113/EP086019. Epub 2016 Dec 12.

46.

The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa.

Jacobson DR, Alexander AA, Tagoe C, Garvey WT, Williams SM, Tishkoff S, Modiano D, Sirima SB, Kalidi I, Toure A, Buxbaum JN.

Mol Genet Genomic Med. 2016 Jul 14;4(5):548-56. doi: 10.1002/mgg3.231. eCollection 2016 Sep.

47.

EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS.

O'Neil PM, Garvey WT, Gonzalez-Campoy JM, Mora P, Ortiz RV, Guerrero G, Claudius B, Pi-Sunyer X; Satiety and Clinical Adiposity – Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups.

Endocr Pract. 2016 Nov;22(11):1277-1287. Epub 2016 Aug 2.

PMID:
27482610
48.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines.

Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines.

Endocr Pract. 2016 Jul;22(7):842-84. doi: 10.4158/EP161356.ESGL.

PMID:
27472012
49.

Trends in Cardiovascular Health Metrics in Obese Adults: National Health and Nutrition Examination Survey (NHANES), 1988-2014.

Guo F, Garvey WT.

J Am Heart Assoc. 2016 Jul 13;5(7). pii: e003619. doi: 10.1161/JAHA.116.003619.

50.

Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders.

Pi-Sunyer X, Shanahan W, Fain R, Ma T, Garvey WT.

Postgrad Med. 2016 Aug;128(6):591-7. doi: 10.1080/00325481.2016.1208618. Epub 2016 Jul 18.

PMID:
27389084

Supplemental Content

Loading ...
Support Center